Results 71 to 80 of about 4,267 (203)

suPAR to Risk-stratify Children with Malaria

open access: yes, 2022
Severe malaria is a leading global cause of childhood morbidity and mortality, particularly in sub-Saharan Africa. However, current malaria diagnostic tests do not reliably identify children at risk of severe disease and death.
Stefanova, Veselina
core  

Does Soluble Urokinase-Type Plasminogen Activator Receptor Level Predicts the Occurrence of Inflammatory Complications in Maxillofacial Surgery?

open access: yesApplied Sciences, 2021
Soluble urokinase-type plasminogen activator receptor (suPAR) is a marker of immune activation and reflects a more distinct aspect of inflammation than C-reactive protein (CRP) does.
Marcin Kozakiewicz   +1 more
doaj   +1 more source

Minimal Evidence of Inflammaging in Naturalistic Chimpanzee Populations

open access: yesAmerican Journal of Biological Anthropology, Volume 189, Issue 2, February 2026.
ABSTRACT Objectives Whereas chronic inflammation is a hallmark of aging in many human populations, inflammaging is reduced in groups characterized by frequent physical activity and diets low in processed foods. Since most biomarkers of inflammation require blood sampling, comparative data from our closest primate relatives have been derived from ...
Megan F. Cole   +6 more
wiley   +1 more source

Social Support as a Determinant of Dietary Quality in Community‐Dwelling Older Adults in China

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
Diet quality and social support play essential roles in maintaining the health of older adults. However, the relationship between these factors remains uncertain. This study aimed to investigate the association between social support and dietary quality among community‐dwelling older adults in China.
Xiaoyan Zhang   +5 more
wiley   +1 more source

Effect of remission induction therapy on the level of soluble urokinase plasminogen activator receptor in acute myeloid leukemia

open access: yesIraqi Journal of Hematology, 2020
BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) in acute myeloid leukemia (AML) is associated with resistance to chemotherapy. The aim is to assess the effect of remission induction on plasma level of suPAR in AML patients and to ...
Eman Qassim Ahmed   +1 more
doaj   +1 more source

Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab

open access: yesBMC Nephrology, 2018
Background Therapeutic plasma exchange (TPE) is an important therapy for recurrent focal segmental glomerulosclerosis (rFSGS) post kidney transplant. suPAR has been causally implicated in rFSGS, and shown to be a unique biomarker for the occurrence and ...
Nada Alachkar   +7 more
doaj   +1 more source

Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit

open access: yesScientific Reports, 2021
Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker and risk factor for kidney diseases, with a potential prognostic value in critically ill patients.
Alexander C. Reisinger   +10 more
doaj   +1 more source

Self-rated health and chronic inflammation are related and independently associated with hospitalization and long-term mortality in the general population

open access: yesScientific Reports, 2022
The subjective indicator of health self-rated health (SRH) and the chronic inflammation biomarker soluble urokinase plasminogen activator receptor (suPAR) are both robust predictors of healthcare use and mortality.
Juliette Tavenier   +7 more
doaj   +1 more source

Enhancing patient stratification methods for medication review during acute admissions

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 11, Page 3279-3287, November 2025.
Medication review in the hospital is an effective tool for identifying inappropriate prescribing, but not every patient can receive one due to resource constraints. Thus, it is important to identify patients who stand to benefit most from medication review.
Louise Westberg Strejby Christensen   +6 more
wiley   +1 more source

A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells [PDF]

open access: yes, 1998
The receptor for urokinase plasminogen activator (uPAR; CD87) is a 50‐ to 65‐kDa glycosylphosphatidylinositol (GPI)‐anchored glycoprotein expressed by leukocytes and tumor cells where it facilitates uPA‐dependent, plasmin‐mediated pericellular ...
Mizukami, Ikuko F.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy